Brief: Aptahem: Good Safety Profile For Apta-1
10/10/2018 10:08
Oct 10 (Reuters) - Aptahem AB APTA.TE :
* APTAHEM REPORTS GOOD SAFETY PROFILE FOR APTA-1 AFTER
CONCLUDED
TOXICOLOGY- AND SAFETY PROGRAM (NON-GLP)
* RESULTS INDICATE THAT HIGHER DOSAGES OF APTA-1, THAN
PREVIOUSLY
ESTIMATED, SHOWS A VERY GOOD SAFETY PROFILE.
* PLANNED START OF CLINICAL TRIALS IN HUMANS IS ESTIMATED
FOR Q3
OF 2019
Source text for Eikon: ID:nWkr9scD0p
Further company coverage: APTA.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Aptahem AB
See all newsBrief: Aptahem Signs Non Binding Term Sheet For Development, Manufacturing And Distribution Of Apta-1 For Sepsis In Europe
Brief: Aptahem Receives Patent Approval In India For Patent Family 1
Brief: Aptahem Rights Issue Oversubscribed
Brief: Aptahem Enters Agreement With Granzer Regulatory Consulting
Brief: Aptahem Largest Shareholder Suggests Dr Bert Junno New Chairman